Xenikos

0 followers


Xenikos is developing a combination of two toxin-loaded anti-T-cell antibodies.

Employees

11-50

Links

Org chart

André de Lege
Controller & Accountant
Maria Marza Perez
CMC Project Manager
Jürgen van de Lagemaat
Director, Process Development & Commercialization

Offices

This company has no offices yet